NCT04615130 (PURE-PE) is a NA clinical trial of Rehabilitation in Pulmonary Embolism, sponsored by Medical University of Vienna.

Who is sponsoring NCT04615130?

NCT04615130 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04615130?

Interventions in NCT04615130: Rehabilitation.

What condition does NCT04615130 study?

NCT04615130 studies Pulmonary Embolism.

Is NCT04615130 still recruiting?

NCT04615130 is currently recruiting now. Last updated 26 September 2025.

Last reviewed 2025-09-26 · How we verify

NCT04615130: PURE-PE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PUlmonary REhabilitation in Patients Suffering From Post-PE Syndrome

Recruiting now NA Last updated 26 September 2025

What this trial tests

NA trial testing Rehabilitation in Pulmonary Embolism in 48 participants. Currently enrolling.

Timeline

1 June 2021

Primary endpoint
31 December 2026

31 December 2027

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	48
Start date	1 June 2021
Primary completion	31 December 2026
Estimated completion	31 December 2027
Sites	1 location across Austria

Drugs / interventions tested

Rehabilitation

Conditions studied

Pulmonary Embolism — all drugs for Pulmonary Embolism →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 90, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a multicenter, parallel, randomized waitlist-controlled trial that primarily focuses on the short-term benefit of outpatient pulmonary rehabilitation (PR) on patients after acute pulmonary embolism. Patients will be randomized into an intervention and a control group. The intervention group will receive 6 weeks of outpatient PR, while patients in the other treatment arm will serve as a control. After completion of the randomized study, the second arm will undergo PR as well.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rehabilitation

Trials testing the same drug.

NCT07320222 — CARE-Melanoma Trial · Phase 1 · not yet recruiting
NCT06926699 — MPFL Reconstruction Versus Rehabilitation · NA · not yet recruiting
NCT06818201 — Effects of tDCS on Motor Cortex During ACL Recovery · NA · recruiting
NCT07105657 — The Outcome of Three Weeks Rehabilitation in Patients With a Total Hip or Knee Replacement Experiencing Persistent Physi · recruiting
NCT06939309 — Efficacy of Acupuncture for Shoulder Pain Based on Remote Point Selection According to the Meridians · NA · not yet recruiting

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

NCT07381712 — High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. · NA · active not recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT07003646 — Reperfusion Treatment in Acute Pulmonary Embolism · recruiting
NCT06600542 — Inari VISION Registry · recruiting
NCT06622876 — Incidental Discovery of Pulmonary Emboli Via CT Scan: Impact of Detections on Patient Care and Resulting Complications · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04615130 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 26 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04615130.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing